Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury

19 December 2020 : Database Analysis

Dali Zhang^1ABCE*, Zhenyu Zhu^1BDF, Jingfeng Bi^2C, Danni Feng^1F, Lijuan Zhang^1CD, Hongling Liu^1DE, Yinjie Gao^1ADFG

DOI: 10.12659/MSM.928849

Med Sci Monit 2020; 26:e928849

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Complications, interventions, and outcomes of COVID-19 patients.

	No. (%)
	Total (n=40)	Normal ALT (n=24)	Elevated ALT (n=16)	P
Complication
Septic shock	0 (0)	0 (0)	0 (0)	–
ARDS	0 (0)	0 (0)	0 (0)	–
Acute kidney injury	2 (5%)	0 (0)	2 (12.5)	0.154
Acute cardiac injury	3 (7.7%)	0 (0)	3 (20%)	0.05
Interventions
Antibiotic	22 (55%)	9 (37.5%)	13 (81.3%)	0.006
Steroid	17 (42.5%)	7 (29.2%)	10 (62.5%)	0.037
Immunoglobin	17 (42.5%)	5 (20.8%)	12 (75%)	0.001
Aerosol of Interferon	38 (95%)	23 (95.8%)	15 (93.8%)	1
Antivirals				0.606
Lopinavir	31 (77.5%)	19 (79.2%)	12 (75.0%)
Arbidol	3 (7.5%)	1 (4.2%)	2 (12.5%)
Outcomes
Discharge	39 (97.5%)	24 (100%)	15 (93.75%)	0.221
Death	1 (2.5%)	0 (0)	1 (6.25%)	1
ARDS – Acute Respiratory Distress Syndrome.

Back to the Article